1. Home
  2. CING vs SYTA Comparison

CING vs SYTA Comparison

Compare CING & SYTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • SYTA
  • Stock Information
  • Founded
  • CING 2012
  • SYTA N/A
  • Country
  • CING United States
  • SYTA Canada
  • Employees
  • CING N/A
  • SYTA N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • SYTA Telecommunications Equipment
  • Sector
  • CING Health Care
  • SYTA Telecommunications
  • Exchange
  • CING Nasdaq
  • SYTA Nasdaq
  • Market Cap
  • CING 16.2M
  • SYTA 17.3M
  • IPO Year
  • CING 2021
  • SYTA 2020
  • Fundamental
  • Price
  • CING $4.36
  • SYTA $3.38
  • Analyst Decision
  • CING Strong Buy
  • SYTA
  • Analyst Count
  • CING 4
  • SYTA 0
  • Target Price
  • CING $30.67
  • SYTA N/A
  • AVG Volume (30 Days)
  • CING 250.6K
  • SYTA 24.9M
  • Earning Date
  • CING 05-08-2025
  • SYTA 05-15-2025
  • Dividend Yield
  • CING N/A
  • SYTA N/A
  • EPS Growth
  • CING N/A
  • SYTA N/A
  • EPS
  • CING N/A
  • SYTA N/A
  • Revenue
  • CING N/A
  • SYTA $11,740,024.00
  • Revenue This Year
  • CING N/A
  • SYTA $18.41
  • Revenue Next Year
  • CING N/A
  • SYTA N/A
  • P/E Ratio
  • CING N/A
  • SYTA N/A
  • Revenue Growth
  • CING N/A
  • SYTA 33.58
  • 52 Week Low
  • CING $1.80
  • SYTA $0.93
  • 52 Week High
  • CING $20.83
  • SYTA $304.15
  • Technical
  • Relative Strength Index (RSI)
  • CING 61.94
  • SYTA 50.26
  • Support Level
  • CING $3.81
  • SYTA $3.00
  • Resistance Level
  • CING $4.09
  • SYTA $8.87
  • Average True Range (ATR)
  • CING 0.26
  • SYTA 1.45
  • MACD
  • CING 0.07
  • SYTA -0.16
  • Stochastic Oscillator
  • CING 96.43
  • SYTA 13.00

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

About SYTA Siyata Mobile Inc.

Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.

Share on Social Networks: